Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They are signals.

Sanofi’s decision not to renew Paul Hudson’s mandate as CEO marks a structural shift — not just for the company, but for how global pharma boards now evaluate performance.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

Free Membership Required

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

China’s Biopharma Strategy: A Warning and Opportunity for India

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

Who Is Accountable for the Medicine in Your Hand?

Topics

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

China’s Biopharma Strategy: A Warning and Opportunity for India

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

Who Is Accountable for the Medicine in Your Hand?

Who Profits From Trust?

The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?

Indian Pharma’s Three Deficits—and Three Potential Dividends

Related Articles

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Company

Headlines

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

China’s Biopharma Strategy: A Warning and Opportunity for India

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

Newsletter